Equities

Zhong Yuan Bio-Technology Holdings Ltd

ZHYBF:PKC

Zhong Yuan Bio-Technology Holdings Ltd

Actions
  • Price (USD)4.99
  • Today's Change0.00 / 0.00%
  • Shares traded99.00
  • 1 Year change+6.62%
  • Beta--
Data delayed at least 15 minutes, as of Oct 15 2024 17:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zhong Yuan Bio-Technology Holdings Ltd is an investment holding company principally engaged in the development and sale of health supplements. The Company operates its business through two segments. The Sales of Health Care Supplements segment is engaged in the development and sale of new drugs for neurological disorders, brain disease detection kits, the sale of plant-derived nervonic acid health supplements as well as others. The Company's main products are nervonic acid series supplements, marketed under the 'Muzhiyuan Neuro Enhancer' brand. The Technical Supporting Services segment is engaged in the provision of technical services.

  • Revenue in USD (TTM)2.49m
  • Net income in USD232.02k
  • Incorporated2018
  • Employees35.00
  • Location
    Zhong Yuan Bio-Technology Holdings LtdSuite 901Tesbury Centre,, 28 Queen's Road EastBEVERLY HILLS 00000Hong KongHKG
  • Phone+852 29198916
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Global Pharmatech Inc.3.18m-2.24m67.19m217.00--0.4959--21.13-0.0964-0.09640.13670.34280.22921.593.5714,649.77-16.44---22.55--46.21---71.75--1.62-9.870.2223--32.43---142.03------
bluebird bio Inc54.90m-311.44m72.97m375.00--1.38--1.33-2.19-2.190.35740.27330.09093.21--146,400.00-51.54-34.75-80.31-40.84-37.34-124.35-567.29-5,770.410.5712-19.810.7827--720.04-11.588.00---30.47--
CASI Pharmaceuticals Inc23.10m-27.21m74.38m176.00--8.24--3.22-2.03-2.031.720.67310.35770.89172.39131,250.00-41.56-34.75-62.38-46.9156.8155.98-116.17-153.722.36--0.6718---21.41--34.27--14.65--
Journey Medical Corp77.68m843.00k76.24m58.0051.009.0718.590.9814-0.0131-0.01313.910.56421.152.365.711,339,328.001.25--5.17--66.79--1.09--1.082.000.6682--7.48--87.00------
OptiNose Inc75.67m-31.15m76.47m132.00------1.01-0.2216-0.22160.5416-0.27250.65120.76592.96573,272.80-26.80-48.25---98.9590.2186.96-41.16-131.660.7198-1.611.48---6.9358.6452.58---27.96--
Assertio Holdings Inc125.76m-68.49m81.80m53.00--0.6269--0.6504-0.7212-0.72121.321.370.38340.90522.342,372,887.00-20.88-21.51-30.33-32.0570.3188.68-54.46-62.101.57--0.2293---2.67-13.38-402.80---28.25--
I-Mab ADR-100.00bn-100.00bn84.12m220.00--0.3579----------2.91-----------35.51---41.43-------509.54----0.00--111.86-13.6544.45---5.95--
Cellectar Biosciences Inc0.00-48.74m84.78m20.00--16.51-----2.51-2.510.000.38390.00----0.00-271.59-83.69-682.65-99.80-----------41.970.00-------32.80--17.55--
Rockwell Medical Inc94.37m-4.77m85.00m237.00--3.47--0.9007-0.169-0.1693.210.75732.0713.9711.61398,194.10-10.48-46.29-16.25-65.3813.444.66-5.06-36.511.60-1.840.3144--14.845.6954.82--76.21--
Zhong Yuan Bio-Technology Holdings Ltd2.49m232.02k88.37m35.00391.37348.44--35.440.0128-0.01760.13950.01430.8583-1.613.2571,253.436.49--19.10--106.30--7.57--0.83092.530.8593---28.60---148.37------
Procaps Group SA414.10m52.20m95.90m5.50k1.632.431.380.23160.52090.52094.160.34910.8541.873.3875,290.1810.77--19.01--55.04--12.61--0.9861--0.8829--0.0434--142.18------
Telomir Pharmaceuticals Inc0.00-18.74m117.85m1.00--75.18-----0.6855-0.68550.000.05290.00----0.00-467.16---686.91-------------0.92990.00-------1,430.39------
Data as of Oct 15 2024. Currency figures normalised to Zhong Yuan Bio-Technology Holdings Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.